These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6047184)

  • 21. [Effect of the addition of the 3rd agent on the combined therapy with ethionamide and kanamycin in tuberculosis in the mice].
    Matsumiya T; Freerksen E; Rosenfeld M
    Jpn J Tuberc Chest Dis; 1970 Jul; 16(1):30-4. PubMed ID: 4991617
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment with secondary antitubercular agents].
    Ovreberg K
    Tidsskr Nor Laegeforen; 1968 May; 88(9):741-9. PubMed ID: 4298856
    [No Abstract]   [Full Text] [Related]  

  • 23. [Comparison of combination therapy of Capreomycin, ethionamide and cycloserin with that of kanamycin, ethionamide and cycloserin for the retreatment of pulmonary tuberculosis].
    Kitamoto O; Oka S; Kawamori Y; Gomi J; Sugiyama K
    Saishin Igaku; 1970 Jul; 25(7):1546-55. PubMed ID: 5451178
    [No Abstract]   [Full Text] [Related]  

  • 24. [Liver function in tuberculosis treated with pyrazinamide, cycloserine, ethionamide and isoniazid].
    Uçak D; Uçak A
    Tip Fak Mecm; 1969; 32(1):48-52. PubMed ID: 5398987
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of pulmonary tuberculosis with ethionamide, cycloserine and pyrazinamide in Hong Kong.
    Horsfall PA
    Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():91-100. PubMed ID: 4662516
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of ethionamide-cycloserine and ethionamide-pyrazinamide regimens in patients resistant to major chemotherapeutics.
    Vidinel I
    Scand J Respir Dis Suppl; 1970; 71():192-5. PubMed ID: 5271985
    [No Abstract]   [Full Text] [Related]  

  • 27. Bacteriological aspects of the use of ethionamide, pyrazinamide and cycloserine in the treatment of chronic pulmonary tuberculosis.
    STEWART SM; HALL E; RIDDELL RW; SOMNER AR
    Tubercle; 1962 Dec; 43():417-31. PubMed ID: 13993194
    [No Abstract]   [Full Text] [Related]  

  • 28. [ETHIONAMIDE IN ASSOCIATION WITH PYRAZINAMIDE OR CYCLOSERINE IN THE TREATMENT OF CHRONIC PULMONARY TUBERCULOSIS].
    WAGNER J
    Gruzlica (1926); 1963 Dec; 31():1217-22. PubMed ID: 14107826
    [No Abstract]   [Full Text] [Related]  

  • 29. Ethionamide, pyrazinamide and cycloserine used successfully in the treatment of chronic pulmonary tuberculosis.
    SOMNER AR; BRACE AA
    Tubercle; 1962 Dec; 43():345-60. PubMed ID: 13978199
    [No Abstract]   [Full Text] [Related]  

  • 30. [A scheme of triple reserve drugs in the treatment of resistant forms of pulmonary tuberculosis].
    Rizzo A; Magalhães M; Moura N
    Hospital (Rio J); 1966 Sep; 70(3):767-83. PubMed ID: 5300283
    [No Abstract]   [Full Text] [Related]  

  • 31. [Various biological tests on several groups of subjects with tuberculosis subjected respectively to monotherapy with isoniazid, viomycin, pyrazinamide, cycloserine, ethioniamide and kanamycin].
    DE SIMONI G; CATTANEO C
    Ann Ist Carlo Forlanini; 1962; 22():326-65. PubMed ID: 14026068
    [No Abstract]   [Full Text] [Related]  

  • 32. Treatment outcome of multidrug-resistant tuberculosis among Vietnamese immigrants.
    Ward HA; Marciniuk DD; Hoeppner VH; Jones W
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):164-9. PubMed ID: 15732735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Combination of ethambutol with ethionamide, cycloserine and-or pyrazynamide in retreatment of pulmonary tuberculosis].
    Kekkaku; 1968 Feb; 43(2):91-5. PubMed ID: 5678013
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bacterial resistance tests against secondary antitubercular agents--reliability of the routine methods].
    Tsukamura M
    Iryo; 1966 Mar; 20(3):241-50. PubMed ID: 5964831
    [No Abstract]   [Full Text] [Related]  

  • 35. [Depot drugs in the treatment of resistant forms of pulmonary tuberculosis. The experience of the Conjunto Sanatorial Octávio de Freitas (Recife)].
    Rizzo A; Moura N; Magalhães M; Antunes G; Campelo C
    Rev Bras Med; 1966 Dec; 23(12):850-2. PubMed ID: 5999012
    [No Abstract]   [Full Text] [Related]  

  • 36. [EVALUATION OF THERAPEUTIC RESULTS IN CHRONIC CAVITARY TUBERCULOSIS TREATED WITH ETHIONAMIDE, CYCLOSERINE AND PYRAZINAMIDE. (A JOINT STUDY ON RESULTS AND PROSPECTS)].
    FORTIC B; KOMAR M
    Tuberkuloza; 1964; 16():359-71. PubMed ID: 14306418
    [No Abstract]   [Full Text] [Related]  

  • 37. Problems of treatment of drug resistance in the developing countries.
    Fox W
    Tubercle; 1969 Mar; 50():Suppl:55-65. PubMed ID: 5402546
    [No Abstract]   [Full Text] [Related]  

  • 38. An investigation of the value of ethionamide with pyrazinamide or cycloserine in the treatment of chronic pulmonary tuberculosis. A report from the Research Committee of the British Tuberculosis Association.
    Tubercle; 1961 Sep; 42():269-86. PubMed ID: 14447359
    [No Abstract]   [Full Text] [Related]  

  • 39. [Comparative results of the therapeutic action of morphazinamide and pyrazinamide combined with ethionamide in experimental tuberculosis in guinea pigs].
    Rözewska M
    G Ital Chemioter; 1967; 14(1):49-57. PubMed ID: 5622725
    [No Abstract]   [Full Text] [Related]  

  • 40. Retreatment of tuberculosis patients with combined drug therapy.
    Feldman J
    Geriatrics; 1969 Nov; 24(11):92-4. PubMed ID: 5349362
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.